Tesamorelin 5 mg

安定化成長ホルモン放出ホルモンアナログ。内臓脂肪組織および IGF-1 軸活性への影響が研究モデルで検討されています。

Tesamorelin is a stabilised analogue of growth-hormone-releasing hormone (GHRH) — modified to extend its half-life relative to native GHRH. It is one of the most studied GHRH-analogue research peptides and the only one of its class to have undergone regulatory approval in any jurisdiction (for HIV-associated lipodystrophy, in the US, under the brand name Egrifta). Quantum Labs supplies Tesamorelin as a lyophilised powder for Australian research applications.

Research on Tesamorelin has covered models of growth-hormone secretion, body composition, lipid metabolism, and IGF-1 dynamics. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.

作用機序

延長された半減期を伴う GHRH 受容体への選択的結合が検討されています。研究では、研究集団における内臓脂肪マーカーの低下と IGF-1 上昇との関連が報告されています。